ABRT:CC News and Press, Albert Labs International Corp. From 05/02/23

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology Canada NewsWire Albert Labs has received preliminary acceptance of 35 novel inventive claims as part of its published International PCT Patent Application (No...

2023-04-25 16:00:00 ET Albert Labs (CSE:ABRT) is gearing up for the first in-human study of its primary drug target, KRN 101, designed as a one dose treatment for cancer-related anxiety and depression, according to CEO and Chairman Dr. Michael Raymont. The company is wrapping up...

Albert Labs announces Private Placement Canada NewsWire Albert Labs has announced a private placement for gross proceeds of up to CAD $3,000,000 , with the first tranche offered at CAD $0.08 /Unit 80% of the Company's First In-Human trial has funding arranged, ...

Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials Canada NewsWire Highlights: Cantheon Capital, one of the largest global pharmaceutical psychedelics venture capital firms, sign terms for ~CA$830,000 (£500,000) of fundi...

Albert Labs Validates Global Supply Chain for Controlled Substances Canada NewsWire VANCOUVER, BC , March 15, 2023 /CNW/ - Albert Labs International Corp. (CSE: ABRT) (FSE: VB50), the "Company" or "Albert Labs"), a fully-integrated biopharmaceutic...

Albert Labs signs Letter of Intent (LOI) with iNGENū CRO for First In-Human Clinical Studies Canada NewsWire VANCOUVER, BC , Nov. 17, 2022 /CNW/ - Albert Labs International Corp. ( Albert Labs (CSE: ABRT) (FSE: VB50), the "Compa...

Albert Labs provides Corporate Update Canada NewsWire VANCOUVER, BC , Oct. 25, 2022 /CNW/ - Albert Labs International Corp. ( Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining r...

Albert Labs Files New International PCT Patent Application for scalable API manufacturing Canada NewsWire VANCOUVER, BC , Oct. 20, 2022 /CNW/ - Albert Labs International Corp. ( Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceu...

Albert Labs Appoints Two Industry Leading Directors Canada NewsWire Albert Labs welcome Mike Thompson , MBE and Katie Shelton-Innes to the Board VANCOUVER, BC , July 11, 2022 /CNW/ - Albert Labs International Corp. (Albert Labs (...

There exists no shortage of treatment options for cancer, from radiotherapy and chemotherapy to experimental options like immunotherapy. Yet, in spite of all the research and experimentation around the disease itself, there are relatively few options for treating cancer's psychological ...